Recent Price Movement and Market Context
On 18 Dec 2025, Bajaj Healthcare's share price touched Rs.394.1, the lowest level recorded in the past year. This decline follows two consecutive days of losses, during which the stock has returned -4.11%. The day’s performance showed a further dip of 0.30%, underperforming its sector by 0.79%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a sustained downward trend in price momentum.
In contrast, the broader market index, Sensex, opened flat and traded marginally lower by 0.01% at 84,552.77 points. The Sensex remains close to its 52-week high of 86,159.02, just 1.9% away, and is supported by bullish moving averages with the 50-day moving average positioned above the 200-day moving average. This divergence highlights Bajaj Healthcare’s relative underperformance compared to the broader market.
Long-Term Performance and Comparative Analysis
Over the last year, Bajaj Healthcare’s stock has delivered a return of -28.47%, significantly lagging behind the Sensex’s 5.45% gain over the same period. This underperformance extends beyond the one-year horizon, with the stock also trailing the BSE500 index across one-year, three-year, and three-month intervals. The 52-week high for Bajaj Healthcare was Rs.744.9, indicating a substantial contraction in market value from its peak.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
Financial Metrics and Debt Position
Bajaj Healthcare’s long-term financial indicators reveal a compound annual growth rate (CAGR) of -5.62% in operating profits over the past five years. This negative growth rate points to challenges in expanding core earnings. The company’s debt servicing capacity is also constrained, with a Debt to EBITDA ratio of 2.59 times, indicating a relatively high leverage level compared to earnings before interest, taxes, depreciation, and amortisation.
Despite these factors, the company reported positive quarterly results in September 2025. Operating profit to interest coverage reached a high of 4.85 times, suggesting that interest obligations were comfortably met during the period. Profit after tax (PAT) for the quarter stood at Rs.13.50 crores, reflecting a growth rate of 77.8%. Additionally, the profit before depreciation, interest, and taxes (PBDIT) was recorded at Rs.26.94 crores, the highest in recent quarters.
Valuation and Return on Capital Employed
Bajaj Healthcare’s return on capital employed (ROCE) is reported at 8.1%, which, while modest, indicates some efficiency in generating returns from capital investments. The enterprise value to capital employed ratio stands at 2.1, suggesting the stock is trading at a discount relative to its peers’ historical valuations. Over the past year, the company’s profits have risen by 52.1%, despite the stock price decline, resulting in a price/earnings to growth (PEG) ratio of 0.8.
Bajaj Healthcare or something better? Our SwitchER feature analyzes this small-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Shareholding and Industry Position
The majority shareholding in Bajaj Healthcare remains with the promoters, maintaining a stable ownership structure. The company operates within the Pharmaceuticals & Biotechnology sector, which has shown mixed performance relative to the broader market indices. Bajaj Healthcare’s recent price movements and financial metrics suggest it is currently facing headwinds within this competitive industry environment.
Summary of Key Price and Performance Indicators
To summarise, Bajaj Healthcare’s stock price has declined to Rs.394.1, marking a 52-week low and reflecting a significant contraction from its 52-week high of Rs.744.9. The stock’s performance over the past year has been notably weaker than the Sensex and sector benchmarks. Financial data points to subdued growth in operating profits over the medium term and a relatively high debt burden. However, recent quarterly results show some improvement in profitability and interest coverage ratios.
While the broader market indices maintain a positive trajectory, Bajaj Healthcare’s share price remains under pressure, trading below all major moving averages and continuing a short-term downward trend. Investors and market participants will likely continue to monitor the company’s financial developments and sector dynamics closely.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Claim Your Free Year →
